Cargando…
Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
OBJECTIVE: To examine associations between dietary intake of omega‐3 (n‐3; generally antiinflammatory) and omega‐6 (n‐6; generally proinflammatory) fatty acids and patient‐reported outcomes in systemic lupus erythematosus (SLE). METHODS: This study was based on the population‐based Michigan Lupus Ep...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842394/ https://www.ncbi.nlm.nih.gov/pubmed/31074595 http://dx.doi.org/10.1002/acr.23925 |
_version_ | 1783468040485076992 |
---|---|
author | Charoenwoodhipong, Prae Harlow, Sioban D. Marder, Wendy Hassett, Afton L. McCune, W. Joseph Gordon, Caroline Helmick, Charles G. Barbour, Kamil E. Wang, Lu Mancuso, Peter Somers, Emily C. Zick, Suzanna M. |
author_facet | Charoenwoodhipong, Prae Harlow, Sioban D. Marder, Wendy Hassett, Afton L. McCune, W. Joseph Gordon, Caroline Helmick, Charles G. Barbour, Kamil E. Wang, Lu Mancuso, Peter Somers, Emily C. Zick, Suzanna M. |
author_sort | Charoenwoodhipong, Prae |
collection | PubMed |
description | OBJECTIVE: To examine associations between dietary intake of omega‐3 (n‐3; generally antiinflammatory) and omega‐6 (n‐6; generally proinflammatory) fatty acids and patient‐reported outcomes in systemic lupus erythematosus (SLE). METHODS: This study was based on the population‐based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n‐3 and n‐6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient‐reported outcomes included self‐reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n‐3 and n‐6, as well as the n‐6:n‐3 ratio, and patient‐reported outcomes. RESULTS: Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean ± SD age was 52.9 ± 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6; P = 0.013) with each unit increase of the n‐6:n‐3 ratio. Both lupus activity and Patient‐Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1‐gram/1,000 kcal increase of n‐3 fatty acids (SLAQ regression coefficient β = –0.8 [95% CI –1.6, 0.0]; P = 0.055; PROMIS sleep β = –1.1 [95% CI –2.0, –0.2]; P = 0.017). Higher n‐3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction. CONCLUSION: This population‐based study suggests that higher dietary intake of n‐3 fatty acids and lower n‐6:n‐3 ratios are favorably associated with patient‐reported outcomes in SLE, particularly self‐reported lupus activity and sleep quality. |
format | Online Article Text |
id | pubmed-6842394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68423942020-07-28 Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program Charoenwoodhipong, Prae Harlow, Sioban D. Marder, Wendy Hassett, Afton L. McCune, W. Joseph Gordon, Caroline Helmick, Charles G. Barbour, Kamil E. Wang, Lu Mancuso, Peter Somers, Emily C. Zick, Suzanna M. Arthritis Care Res (Hoboken) Systemic Lupus Erythematosus OBJECTIVE: To examine associations between dietary intake of omega‐3 (n‐3; generally antiinflammatory) and omega‐6 (n‐6; generally proinflammatory) fatty acids and patient‐reported outcomes in systemic lupus erythematosus (SLE). METHODS: This study was based on the population‐based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n‐3 and n‐6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient‐reported outcomes included self‐reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n‐3 and n‐6, as well as the n‐6:n‐3 ratio, and patient‐reported outcomes. RESULTS: Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean ± SD age was 52.9 ± 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6; P = 0.013) with each unit increase of the n‐6:n‐3 ratio. Both lupus activity and Patient‐Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1‐gram/1,000 kcal increase of n‐3 fatty acids (SLAQ regression coefficient β = –0.8 [95% CI –1.6, 0.0]; P = 0.055; PROMIS sleep β = –1.1 [95% CI –2.0, –0.2]; P = 0.017). Higher n‐3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction. CONCLUSION: This population‐based study suggests that higher dietary intake of n‐3 fatty acids and lower n‐6:n‐3 ratios are favorably associated with patient‐reported outcomes in SLE, particularly self‐reported lupus activity and sleep quality. John Wiley and Sons Inc. 2020-06-29 2020-07 /pmc/articles/PMC6842394/ /pubmed/31074595 http://dx.doi.org/10.1002/acr.23925 Text en © 2019, The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Systemic Lupus Erythematosus Charoenwoodhipong, Prae Harlow, Sioban D. Marder, Wendy Hassett, Afton L. McCune, W. Joseph Gordon, Caroline Helmick, Charles G. Barbour, Kamil E. Wang, Lu Mancuso, Peter Somers, Emily C. Zick, Suzanna M. Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program |
title | Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program |
title_full | Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program |
title_fullStr | Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program |
title_full_unstemmed | Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program |
title_short | Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program |
title_sort | dietary omega polyunsaturated fatty acid intake and patient‐reported outcomes in systemic lupus erythematosus: the michigan lupus epidemiology and surveillance program |
topic | Systemic Lupus Erythematosus |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842394/ https://www.ncbi.nlm.nih.gov/pubmed/31074595 http://dx.doi.org/10.1002/acr.23925 |
work_keys_str_mv | AT charoenwoodhipongprae dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT harlowsioband dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT marderwendy dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT hassettaftonl dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT mccunewjoseph dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT gordoncaroline dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT helmickcharlesg dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT barbourkamile dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT wanglu dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT mancusopeter dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT somersemilyc dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram AT zicksuzannam dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram |